Quantbot Technologies’s Oruka Therapeutics ORKA Stock Holding History

Quantbot Technologies’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3	Closed	–	–	1749
2020 Q3	$0	Buy	+3	New	+$212	﹤0.01%	1695

Other funds holding ORKA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quantbot Technologies's ORKA Position: Q4 2020 in Review

Quantbot Technologies sold out of Oruka Therapeutics (ORKA) in Q4 2020, closing a stake of 3 shares.

Quantbot Technologies first reported a position in ORKA in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 20 funds tracked by Wall St. Rank hold ORKA as of Q4 2020.

Quantbot Technologies reported no remaining Oruka Therapeutics position as of Q4 2020 after selling out during the quarter.
Quantbot Technologies sold 3 Oruka Therapeutics shares in Q4 2020.
Quantbot Technologies first reported a position in Oruka Therapeutics in Q3 2020 and held it in 1 quarter.
Quantbot Technologies's Oruka Therapeutics position peaked at $0 in Q3 2020.
20 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q4 2020.

Based on Quantbot Technologies's 13F filing for Q4 2020, filed 12 Feb 2021.